BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src AND Clinical Outcome
7 results:

  • 1. Serotonin/HTR1E signaling blocks chronic stress-promoted progression of ovarian cancer.
    Qin X; Li J; Wang S; Lv J; Luan F; Liu Y; Chen Y; Chen X; Zhao Y; Zhu J; Piao Y; Zhang W; Shi Y; Xiang R; Qu P; Wang L
    Theranostics; 2021; 11(14):6950-6965. PubMed ID: 34093864
    [No Abstract]    [Full Text] [Related]  

  • 2. Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation.
    Zhang Q; Zhou W; Yu S; Ju Y; To SKY; Wong AST; Jiao Y; Poon TCW; Tam KY; Lee LTO
    Oncogene; 2021 Jan; 40(1):97-111. PubMed ID: 33082557
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of src signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A Direct Podocalyxin-Dynamin-2 Interaction Regulates Cytoskeletal Dynamics to Promote Migration and Metastasis in Pancreatic cancer Cells.
    Wong BS; Shea DJ; Mistriotis P; Tuntithavornwat S; Law RA; Bieber JM; Zheng L; Konstantopoulos K
    Cancer Res; 2019 Jun; 79(11):2878-2891. PubMed ID: 30975647
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.
    Schilder RJ; Brady WE; Lankes HA; Fiorica JV; Shahin MS; Zhou XC; Mannel RS; Pathak HB; Hu W; Alpaugh RK; Sood AK; Godwin AK
    Gynecol Oncol; 2012 Oct; 127(1):70-4. PubMed ID: 22710075
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma.
    Trinh XB; Tjalma WA; Dirix LY; Vermeulen PB; Peeters DJ; Bachvarov D; Plante M; Berns EM; Helleman J; Van Laere SJ; van Dam PA
    PLoS One; 2011; 6(7):e22469. PubMed ID: 21799864
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The role of oestrogen receptor {alpha} in human thyroid cancer: contributions from coregulatory proteins and the tyrosine kinase receptor HER2.
    Kavanagh DO; McIlroy M; Myers E; Bane F; Crotty TB; McDermott E; Hill AD; Young LS
    Endocr Relat Cancer; 2010 Mar; 17(1):255-64. PubMed ID: 20032008
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.